JBIO compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

JBIOJade Biosciences, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

JBIOJade Biosciences, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

JBIOJade Biosciences, Inc.

14.70▲+4.23%

Mkt cap$896.7MRevenue—Revenue—

LLYELI Lilly & Co

1,362.40▼−0.17%

Regular sessionNov 6 '26

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Regular sessionNov 6 '26

JBIOJade Biosciences, Inc.

LLYELI Lilly & Co

14.70▲+4.23%

Price

1,362.40▼−0.17%

$896.7M

Mkt cap

$1.2T

—

Revenue

$24.4BQ3 FY26

—

Revenue

$65.2BFY25

JBIO14.70▲+4.23%vsLLY1,362.40▼−0.17%Regular sessionNov 6 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only JBIO 3

—Patheon Biologicsunlistedsupplier

—WuXi Biologics (Hong Kong)unlistedsupplier

—WuXi Biologics Irelandunlistedsupplier

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›